31 results on '"Fujimoto, Daichi"'
Search Results
2. Proteomics associated with coronary high-risk plaques by optical coherence tomography
3. Rocuronium action can be affected by hyperventilation: a case report and computational simulation
4. Prediction of the debulking effect of rotational atherectomy using optical frequency domain imaging: a prospective study
5. Pneumonitis associated with pembrolizumab plus chemotherapy for non-squamous non-small cell lung cancer
6. Sputum characteristics of patients with severe COVID-19: report of two cases with immunocytochemical detection of SARS-CoV-2 spike protein
7. Real-world clinical outcomes of percutaneous transluminal septal myocardial ablation for patients with drug-refractory hypertrophic obstructive cardiomyopathy: results from a retrospective multicenter registry of non-high-volume centers
8. Classification and regression tree for estimating predictive markers to detect T790M mutations after acquired resistance to first line EGFR-TKI: HOPE-002
9. Predictor analysis of 1-year restenosis after percutaneous transluminal angioplasty for femoropopliteal stenotic lesions using intravascular ultrasound
10. Clinical factors associated with shorter durable response, and patterns of acquired resistance to first-line pembrolizumab monotherapy in PD-L1-positive non-small-cell lung cancer patients: a retrospective multicenter study
11. Durvalumab for patients with unresectable stage III non-small cell lung cancer and grade 1 radiation pneumonitis following concurrent chemoradiotherapy: a multicenter prospective cohort study
12. Long-term preoperative glycemic control restored the perioperative neutrophilic phagocytosis activity in diabetic mice
13. Tumour content ratio matters for detecting epidermal growth factor receptor mutation by cobas test in small biopsies; a retrospective study
14. Differential significance of molecular subtypes which were classified into EGFR exon 19 deletion on the first line afatinib monotherapy
15. Prediction of patients with a tumor proportion score > 50% who do not respond to first-line monotherapy with pembrolizumab
16. Reply from authors: The association of intraoperative end-tidal carbon dioxide with the risk of postoperative nausea and vomiting
17. Association between metastatic sites and first-line pembrolizumab treatment outcome for advanced non–small cell lung cancer with high PD-L1 expression: a retrospective multicenter cohort study
18. The association of intraoperative end-tidal carbon dioxide with the risk of postoperative nausea and vomiting
19. Osimertinib in a patient with non-small cell lung cancer and renal failure undergoing hemodialysis: a case report
20. Efficacy and safety of pembrolizumab as first-line therapy in advanced non-small cell lung cancer with at least 50% PD-L1 positivity: a multicenter retrospective cohort study (HOPE-001)
21. Ineligibility for the PACIFIC trial in unresectable stage III non-small cell lung cancer patients
22. Early depth of tumor shrinkage and treatment outcomes in non-small cell lung cancer treated using Nivolumab
23. Successful oral desensitization with osimertinib following osimertinib-induced fever and hepatotoxicity: a case report
24. Exacerbation of autoimmune hemolytic anemia induced by the first dose of programmed death-1 inhibitor pembrolizumab: a case report
25. Concordance between the response evaluation criteria in solid tumors version 1.1 and the immune-related response criteria in patients with non-small cell lung cancer treated with nivolumab: a multicenter retrospective cohort study
26. Alteration of PD-L1 expression and its prognostic impact after concurrent chemoradiation therapy in non-small cell lung cancer patients
27. Comparison of the incidences of hyponatremia in adult postoperative critically ill patients receiving intravenous maintenance fluids with 140 mmol/L or 35 mmol/L of sodium: retrospective before/after observational study
28. The prognostic value of serum CA 19-9 for patients with advanced lung adenocarcinoma
29. The safety and efficacy of paclitaxel and carboplatin with or without bevacizumab for treating patients with advanced nonsquamous non-small cell lung cancer with interstitial lung disease
30. Features and prognostic impact of distant metastasis in patients with stage IV lung adenocarcinoma harboring EGFR mutations: importance of bone metastasis
31. Association between vascular-poor area of primary tumors and epidermal growth factor receptor gene status in advanced lung adenocarcinoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.